Drug Type Small molecule drug |
Synonyms- |
Target |
Action modulators |
Mechanism PTGES2 modulators(prostaglandin E synthase 2 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Pancreatic Ductal Adenocarcinoma | Preclinical | - | 13 Dec 2022 | |
| Acute Myeloid Leukemia | Preclinical | - | 11 Dec 2022 |





